Genes whose transcript abundance decreased less than half after exposure to N₂O₅ gas compared to air control in RNA-seq analysis. by Daiki Tsukidate (12936828)

Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

“…<p>(A) A375 melanoma cells were treated with 0.5 μM, 1.0 μM, or 2.0 μM 5-, 10-, or 16-TPP for 1 h and analyzed for mitochondria membrane potential by the JC-1 method (* significant relative to control; p<0.05; n = 2 from 2 separate experiments; N = 4). …”

Cellular co-infection decreases the potential for superinfection. by Brigitte E. Martin (8366847)

The human neutrophil IL-1β secretory response, in contrast to the CXCL8/IL-8 secretory response decreases as MOI increases. by Florencia Sabbione (4862455)

DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…Error bars indicated SEM. CHPG, α-amino-2-chloro-5-hydroxybenzeneacetic acid; DHPG, (S)-3,5-Dihydroxyphenylglycine; GABA_A receptor, γ-Aminobutyric acid type A receptor; GDP-β-S, Guanosine 5ʹ-O-(2-Thiodiphosphate); GlyR, glycine receptor; IPSC, inhibitory postsynaptic current; mGluR5, metabotropic glutamate receptor 5; MPEP, 6-Methyl-2-(phenylethynyl) pyridine; PD98059, 2ʹ-Amino-3ʹ-methoxyflavone; Ro-32-0432, 2-{8-[(Dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-3-yl}-3-(1-methyl-1H-indol-3-yl)maleimide.…”

RAC1 inhibition results in a decrease in oxidative phosphorylation. by Shruthi Sriramkumar (12705564)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

Brain uptake of [³H]mannitol in 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

Tom clone number and area decrease during pupariation. by Jeremy Brown (3311742)

CLE mutation decreases H3K27me3 levels on the viral IR. by Jacqueline Williams (3493745)

VOC Alpha spike protein shows decreased proteolytic processing. by Daniela Niemeyer (199082)

Disruption of putative host factor LGMN decreases SARS-CoV-2 viral entry. by Ravi K. Dinesh (21736629)

Ppk1 levels are not affected by decreasing dendrite arbor size but are reduced when dendrite length increases. by Josephine W. Mitchell (17364781)

Rcan2-mediated decrease in intracellular K⁺ involves Kcnk5b. by Xiaowen Jiang (8291814)

Excessive LF4A kinase activity shortens cilia and decreases IFT. by Yu-Yang Jiang (7036916)

SARS-CoV-2 decreases excitatory synapses, while influenza A does not induce cell death in BCO. by Pinar Mesci (14053895)

Firing rates of PNs (as maximum activity) in response to a single synchronous triangular pulse of 50 ms duration applied to both ORN groups. by Mario Pannunzi (553941)